$ETNB
89bio, Inc.

2022 Q4 Form 10-Q Financial Statement

#000156459022037425 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.298M $4.844M $4.622M
YoY Change 19.69% 4.8% 43.1%
% of Gross Profit
Research & Development $19.06M $22.20M $23.59M
YoY Change -9.13% -5.91% 110.44%
% of Gross Profit
Depreciation & Amortization $15.00K $16.00K $23.00K
YoY Change -28.57% -30.43% 15.0%
% of Gross Profit
Operating Expenses $25.36M $27.04M $28.21M
YoY Change -3.35% -4.15% 95.51%
Operating Profit -$27.04M -$28.21M
YoY Change -4.15%
Interest Expense $535.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $776.0K $238.0K -$117.0K
YoY Change -500.0% -303.42% -22.0%
Pretax Income -$24.59M -$26.80M -$28.33M
YoY Change -6.99% -5.39% 94.3%
Income Tax $16.00K $2.000K $0.00
% Of Pretax Income
Net Earnings -$24.60M -$26.81M -$28.33M
YoY Change -6.41% -5.38% 93.99%
Net Earnings / Revenue
Basic Earnings Per Share -$0.57 -$1.41
Diluted Earnings Per Share -$0.48 -$0.57 -$1.410M
COMMON SHARES
Basic Shares Outstanding 46.54M 39.07M 20.09M
Diluted Shares Outstanding 47.25M 20.09M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $188.2M $193.3M $157.3M
YoY Change 24.84% 22.89% -28.22%
Cash & Equivalents $55.26M $72.40M $39.70M
Short-Term Investments $132.9M $120.9M $117.6M
Other Short-Term Assets $7.920M $6.513M $9.703M
YoY Change -29.68% -32.88% 185.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $196.1M $199.9M $167.0M
YoY Change 21.05% 19.65% -24.93%
LONG-TERM ASSETS
Property, Plant & Equipment $92.00K $105.0K $146.0K
YoY Change -38.67% -28.08% -27.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $289.0K $218.0K $874.0K
YoY Change -0.34% -75.06% 24.86%
Total Long-Term Assets $744.0K $726.0K $1.020M
YoY Change 69.09% -28.82% 13.33%
TOTAL ASSETS
Total Short-Term Assets $196.1M $199.9M $167.0M
Total Long-Term Assets $744.0K $726.0K $1.020M
Total Assets $196.8M $200.6M $168.1M
YoY Change 21.18% 19.35% -24.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.50M $14.15M $12.53M
YoY Change 82.7% 12.97% 205.51%
Accrued Expenses $11.94M $13.44M $7.319M
YoY Change 17.17% 83.59% 38.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $6.667M
YoY Change -100.0%
Total Short-Term Liabilities $24.61M $34.42M $19.85M
YoY Change 25.99% 73.46% 111.12%
LONG-TERM LIABILITIES
Long-Term Debt $19.69M $12.96M $1.441M
YoY Change 16.53% 799.24%
Other Long-Term Liabilities $687.0K $624.0K
YoY Change 2190.0%
Total Long-Term Liabilities $19.69M $12.96M $1.441M
YoY Change 16.53% 799.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.61M $34.42M $19.85M
Total Long-Term Liabilities $19.69M $12.96M $1.441M
Total Liabilities $44.99M $48.01M $21.29M
YoY Change 23.38% 125.52% 126.45%
SHAREHOLDERS EQUITY
Retained Earnings -$315.2M -$290.6M -$186.9M
YoY Change 47.85% 55.48%
Common Stock $467.4M $443.7M
YoY Change 37.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $151.8M $152.6M $146.8M
YoY Change
Total Liabilities & Shareholders Equity $196.8M $200.6M $168.1M
YoY Change 21.18% 19.35% -24.77%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$24.60M -$26.81M -$28.33M
YoY Change -6.41% -5.38% 93.99%
Depreciation, Depletion And Amortization $15.00K $16.00K $23.00K
YoY Change -28.57% -30.43% 15.0%
Cash From Operating Activities -$27.10M -$14.81M -$13.45M
YoY Change -4.05% 10.15% 3.94%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $0.00 -$16.00K
YoY Change -107.41% -100.0% 60.0%
Acquisitions
YoY Change
Other Investing Activities -$11.06M -$42.06M $17.38M
YoY Change -157.86% -342.06% -124.14%
Cash From Investing Activities -$11.06M -$42.06M $17.36M
YoY Change -157.95% -342.28% -124.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.01M 68.63M 72.00K
YoY Change -4.02% 95220.83% -99.95%
NET CHANGE
Cash From Operating Activities -27.10M -14.81M -13.45M
Cash From Investing Activities -11.06M -42.06M 17.36M
Cash From Financing Activities 21.01M 68.63M 72.00K
Net Change In Cash -17.15M 11.76M 3.981M
YoY Change -234.62% 195.35% -94.57%
FREE CASH FLOW
Cash From Operating Activities -$27.10M -$14.81M -$13.45M
Capital Expenditures $2.000K $0.00 -$16.00K
Free Cash Flow -$27.10M -$14.81M -$13.43M
YoY Change -3.95% 10.28% 3.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19537000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12958000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16898000
CY2021Q4 etnb Other Non Current Liability
OtherNonCurrentLiability
30000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63502000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26805000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28329000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-136000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28327000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77800000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63818000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20092094
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20092094
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72401000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11237000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
161982000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2512000
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001785173
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-06-30
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.899
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.940
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.976
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.010
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39122
dei Entity Registrant Name
EntityRegistrantName
89bio, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4946844
dei Entity Address Address Line1
EntityAddressAddressLine1
142 Sansome Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Second Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
432-9270
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ETNB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46536970
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52432000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2022Q3 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
120940000
CY2021Q4 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
98288000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6513000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
199854000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
403000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
150000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
218000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
290000
CY2022Q3 us-gaap Assets
Assets
200580000
CY2021Q4 us-gaap Assets
Assets
162422000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
14151000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6843000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13437000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10194000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
168000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6667000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
34423000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229000
CY2022Q3 etnb Other Non Current Liability
OtherNonCurrentLiability
395000
CY2022Q3 us-gaap Liabilities
Liabilities
48005000
CY2021Q4 us-gaap Liabilities
Liabilities
36465000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
44000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
443612000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
339218000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-440000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-290641000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213217000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
152575000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
125957000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
200580000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
162422000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22197000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23590000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61732000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49351000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4844000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4622000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15155000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14151000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
27041000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
28212000
us-gaap Operating Expenses
OperatingExpenses
76887000
us-gaap Operating Expenses
OperatingExpenses
63502000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27041000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-28212000
us-gaap Operating Income Loss
OperatingIncomeLoss
-76887000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
238000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-117000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-534000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-332000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26803000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28329000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77421000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63834000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Net Income Loss
NetIncomeLoss
-77424000
us-gaap Net Income Loss
NetIncomeLoss
-63834000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-408000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-122000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-376000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26927000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.41
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.18
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47253527
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47253527
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29413421
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29413421
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20043301
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20043301
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
125957000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25565000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-192000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
102741000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
43000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-69000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2586000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-25054000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
80185000
CY2022Q3 etnb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
53000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
208000
CY2022Q3 etnb Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
-53000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2500000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26805000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-122000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
152575000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
202961000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
216000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1793000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14782000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
190195000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
152000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
83000
CY2021Q2 etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
574000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2417000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-20723000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
172705000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
78000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2314000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28329000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
146770000
us-gaap Profit Loss
ProfitLoss
-77424000
us-gaap Profit Loss
ProfitLoss
-63834000
us-gaap Share Based Compensation
ShareBasedCompensation
7598000
us-gaap Share Based Compensation
ShareBasedCompensation
6524000
etnb Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
365000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
227000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
392000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
183000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-704000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
135000
us-gaap Depreciation
Depreciation
50000
us-gaap Depreciation
Depreciation
58000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4756000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4119000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-72000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7308000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10459000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3243000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1271000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-141000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53994000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48541000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
87260000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
107627000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
110137000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
119518000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22882000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11927000
etnb Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
88239000
etnb Proceeds From Issuance Public Offering At The Market Offering
ProceedsFromIssuancePublicOfferingAtTheMarketOffering
8370000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
237000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
446000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
53000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
83000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
122000
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
1451000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96820000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1980000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19944000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-58488000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52457000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98208000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72401000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39720000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72401000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39695000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72401000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39720000
us-gaap Interest Paid Net
InterestPaidNet
706000
us-gaap Interest Paid Net
InterestPaidNet
1000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
187000
etnb Remeasurement Of Lease Liability And Right Of Use Asset In Connection With Lease Modification
RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification
338000
etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
574000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
193300000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.4%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include but are not </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">limited to the fair value of stock options and certain accru</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed expenses</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings
0
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
809000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
836000
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
729000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2506000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
163790000
CY2022Q3 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
6159000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
169949000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
120726000
CY2021Q4 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
5277000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
126003000
CY2022Q3 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
4975000
CY2021Q4 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
7895000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6513000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11237000
CY2022Q3 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
9621000
CY2021Q4 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
6195000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2811000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3168000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
696000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
495000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
309000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
336000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13437000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10194000
CY2022Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
47000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
CY2022Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y3M18D
etnb Operating Lease Liability Percentage
OperatingLeaseLiabilityPercentage
0.0650
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
49000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
185000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
185000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
426000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
29000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
397000
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
70000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
212000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
219000
etnb Percentage Of Fee On Loan
PercentageOfFeeOnLoan
0.050
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
500000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
10000000
us-gaap Interest Expense Debt
InterestExpenseDebt
1400000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10000000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20000000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
375000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
19625000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6667000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12958000
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
19132331
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18158782
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2500000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2314000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7598000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6524000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17621091
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2577202

Files In Submission

Name View Source Status
0001564590-22-037425-index-headers.html Edgar Link pending
0001564590-22-037425-index.html Edgar Link pending
0001564590-22-037425.txt Edgar Link pending
0001564590-22-037425-xbrl.zip Edgar Link pending
etnb-10q_20220930.htm Edgar Link pending
etnb-20220930.xsd Edgar Link pending
etnb-ex101_12.htm Edgar Link pending
etnb-ex311_7.htm Edgar Link pending
etnb-ex312_6.htm Edgar Link pending
etnb-ex32_8.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
etnb-20220930_lab.xml Edgar Link unprocessable
etnb-10q_20220930_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
etnb-20220930_pre.xml Edgar Link unprocessable
etnb-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
etnb-20220930_cal.xml Edgar Link unprocessable